Researchers from around the world are sharing the most important discoveries in global cancer care during the ASCO20 Virtual Scientific Program May 29-31. Among the featured science will be 31 studies first-authored by researchers previously funded by Conquer Cancer, the ASCO Foundation.
“We’re so proud to have the work of so many Conquer Cancer researchers showcased at the ASCO20 Virtual Scientific Program,” said Nancy R. Daly, MS, MPH, chief philanthropic officer for Conquer Cancer. “When donors make it possible for Conquer Cancer to fund researchers studying every type of cancer, especially at the onset of their research careers, their investment pays off for patients year after year.”
Among the researchers presenting at the virtual meeting is Stephanie Lheureux, MD, PhD, a 2019 Career Development Award (CDA) recipient. Dr. Lheureux is presenting Learning from the Biology: Advances in Endometrial and Ovarian Cancer at the Clinical Science Symposium.
The study: In a randomized, phase II trial doctors tested drug combinations on patients with recurrent endometrial cancer. One group was given the drugs cabozantinib and nivolumab; one group was given only nivolumab.
The results: The combination of drugs significantly increased progression free survival rates compared to a single drug approach.
Additional research presented by Conquer Cancer grant recipients includes new information in cancer prevention, immunotherapy, and treatments of colon, lung, breast, and brain cancer.
Click here for the complete research listing from the Virtual Scientific Program